As the J.P. Morgan Healthcare Conference continues to roll on with companies showcasing their pipelines and business plans, negative reports about the host city San Francisco have been made.
CMI/Compas – media strategy, planning, innovation and buying for the nation’s top healthcare companies and part of WPP – has created a Growth & Innovation practice to keep clients ahead of the curve by prioritizing and investing in innovation.
BioNTech will acquire Neon Therapeutics Inc. in an all-stock transaction valued at approximately $67 million.
With the 2020 elections looming though, and lawmakers across the country drafting legislation aimed at curbing price increases, some companies are carefully examining the landscape as they approach pricing.
Although there were some deals announced at the ongoing J.P. Morgan Healthcare Conference, biotech stocks appeared to slide slightly at the overall lack of business transactions, at least during the first day or two.
Takeda Pharmaceutical has been on a tear over the past few weeks, striking deals to develop new therapies for various diseases. Now the Japan-based pharma powerhouse has announced a multi-year drug discovery deal with Charles River Laboratories.
Roche is expecting the U.S. Food and Drug Administration to approve the company’s SMA therapy risdiplam by May 24, 2020, and has suggested plans to undercut both Biogen and Novartis on price in order to make up for being third-to-market.
At the JP Morgan Healthcare Conference in San Francisco, Illumina CEO Francis deSouza announced a 15-year non-exclusive deal with Roche to increase the availability of next-generation sequencing-based in vitro diagnostic tests on Illumina’s diagnostic sequencing systems.
GlaxoSmithKline CEO Emma Walmsley is anticipating a good 2020 for her company, with the potential of six regulatory approvals in the United States.
Eli Lilly and Co. plans to sell two versions of insulin products at half their current U.S. list prices, eight months after the drug manufacturer started selling a half-priced version of the widely used Humalog injection.
